Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook basliginda one cikan gelisme: Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.

Fonvera editor notu: Haberin piyasa etkisini izlemek icin ilgili varlik sayfalari ve ekonomik takvim akisi birlikte okunmalidir.

Orijinal kaynak: CNBC